Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?

Detalles Bibliográficos
Autores principales: Ishida, Junichi, Konishi, Masaaki, Saito, Masakazu, Springer, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670748/
https://www.ncbi.nlm.nih.gov/pubmed/26674220
http://dx.doi.org/10.1002/jcsm.12080
_version_ 1782404306344869888
author Ishida, Junichi
Konishi, Masaaki
Saito, Masakazu
Springer, Jochen
author_facet Ishida, Junichi
Konishi, Masaaki
Saito, Masakazu
Springer, Jochen
author_sort Ishida, Junichi
collection PubMed
description
format Online
Article
Text
id pubmed-4670748
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-46707482015-12-15 Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer? Ishida, Junichi Konishi, Masaaki Saito, Masakazu Springer, Jochen J Cachexia Sarcopenia Muscle Letters to the Editor John Wiley & Sons, Ltd 2015-12 2015-10-27 /pmc/articles/PMC4670748/ /pubmed/26674220 http://dx.doi.org/10.1002/jcsm.12080 Text en © 2015 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society of Sarcopenia, Cachexia and Wasting Disorders http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Letters to the Editor
Ishida, Junichi
Konishi, Masaaki
Saito, Masakazu
Springer, Jochen
Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
title Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
title_full Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
title_fullStr Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
title_full_unstemmed Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
title_short Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
title_sort hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670748/
https://www.ncbi.nlm.nih.gov/pubmed/26674220
http://dx.doi.org/10.1002/jcsm.12080
work_keys_str_mv AT ishidajunichi hypermetabolismshouldcancertypespathologicalstagesandracesbeconsideredinassessingmetabolismandcouldelevatedrestingenergyexpenditurebethetherapeutictargetinpatientswithadvancedcancer
AT konishimasaaki hypermetabolismshouldcancertypespathologicalstagesandracesbeconsideredinassessingmetabolismandcouldelevatedrestingenergyexpenditurebethetherapeutictargetinpatientswithadvancedcancer
AT saitomasakazu hypermetabolismshouldcancertypespathologicalstagesandracesbeconsideredinassessingmetabolismandcouldelevatedrestingenergyexpenditurebethetherapeutictargetinpatientswithadvancedcancer
AT springerjochen hypermetabolismshouldcancertypespathologicalstagesandracesbeconsideredinassessingmetabolismandcouldelevatedrestingenergyexpenditurebethetherapeutictargetinpatientswithadvancedcancer

Ejemplares similares